Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...

Tonix Pharmaceuticals Holding Corp (TNXP) stock saw a modest uptick, ending the day at $0.24 which represents a slight increase of $0.01 or 4.35% from the prior close of $0.23. The stock opened at $0.

Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration, FDA, has accepted the filing of its New Drug Application, ...

Tonix Pharmaceuticals Holding Corp (TNXP) stock saw a modest uptick, ending the day at $0.23 which represents a slight increase of $0.03 or 15.00% from the prior close of $0.2. The stock opened at $0.

Tonix Pharma ( (TNXP) ) has provided an announcement.

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the stock.

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 ...

(Nasdaq: TNXP) announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ...

Shares of Corvus Pharmaceuticals, Inc. CRVS +18.3% + Free Alerts rose sharply in today's pre-market trading after the company ...